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Cardiology providers’ recommendations
for treatments and use of patient decision aids
for multivessel coronary artery disease
Elizabeth L. Nichols1*, Glyn Elwyn1, Anthony DiScipio2, Mandeep S. Sidhu3,4, A. James O’Malley1,
Daniel D. Matlock5, Shama Alam1, Cathy S. Ross2, Megan Coylewright2, David J. Malenka2 and
Jeremiah R. Brown1

Abstract
Background: Rates of recommending percutaneous coronary intervention (PCI) and coronary artery bypass grafting
(CABG) vary across clinicians. Whether clinicians agree on preferred treatment options for multivessel coronary artery
disease patients has not been well studied.
Methods and results: We distributed a survey to 104 clinicians from the Northern New England Cardiovascular
Study Group through email and at a regional meeting with 88 (84.6%) responses. The survey described three clinical
vignettes of multivessel coronary artery disease patients. For each patient vignette participants selected appropriate treatment options and whether they would use a patient decision aid. The likelihood of choosing PCI only or
PCI/CABG over CABG only was modeled using a multinomial regression. Across all vignettes, participants selected
CABG only as an appropriate treatment option 24.2% of the time, PCI only 25.4% of the time, and both CABG or PCI
as appropriate treatment options 50.4% of the time. Surgeons were less likely to choose PCI over CABG (RR 0.14, 95%
CI 0.03, 0.59) or both treatments over CABG only (RR 0.10, 95% CI 0.03, 0.34) relative to cardiologists. Overall, 65% of
participants responded they would use a patient decision aid with each vignette.
Conclusions: There is a lack of consensus on the appropriate treatment options across cardiologists and surgeons for
patients with multivessel coronary artery disease. Treatment choice is influenced by both patient characteristics and
clinician specialty.
Introduction
The ratio of percutaneous coronary intervention (PCI) to
coronary artery bypass grafting (CABG) varies between
hospitals across the United States and Canada [1, 2].
Coronary anatomy, indication, hospital culture, clinician
recommendation, and availability of procedures influence
whether a patient receives PCI or CABG [1]. Additionally
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clinician recommendation influences the PCI to CABG
ratio at institutions [1]. Although prior studies demonstrate clinicians have different rates of recommending
treatment options for coronary artery disease, we do not
know whether clinicians agree on the treatment options
that could be considered appropriate options for patients.
Differences among clinicians’ treatment strategy
choices have previously been studied using surveys with
clinical vignettes [3, 4]. Vignette surveys have been used
to examine variation in physicians’ diagnosis of coronary
artery disease, recommendations for self-management,
and antibiotic prescribing practices [5–7]. In France, cardiologists answered questions about two clinical vignettes
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to determine the practice patterns for stable coronary
artery disease management [8]. Clinicians varied in their
diagnostic test strategies, with 24% immediately requesting coronary angiography, 49% requesting stress testing,
and 27% using medial therapy without further diagnostic
testing for recurrent stable angina patients [8]. A Dutch
study used vignettes to assess which clinical factors, such
as troponins or renal function, cardiologists prioritized
when deciding whether to perform coronary angiography
in patients with suspected NSTEMI [9]. There is not, to
our knowledge, a vignette study assessing which treatment options clinicians consider appropriate for multivessel coronary artery disease patients.
Shared decision making is recommended for patients
where treatment options offer different pros and cons,
and where there may be more than one appropriate treatment. Previous shared decision making implementation
projects have documented low agreement among healthcare professionals in the appropriate approach to shared
decision making [10]. A review of five encounter decision
aid trials showed variability in how and when clinicians
used decision aids [11]. Past studies have shown clinicians are more likely to support shared decision making
when there is no strong preference for one treatment
option. Support for shared decision making is reduced
when a specific treatment option is favored [12]. It is
important to determine whether clinicians consider more
than one treatment option appropriate in a clinical scenario when proposing a patient decision aid. In multivessel disease, using a clinical vignette study allows us to
additionally study clinicians’ willingness to use a patient
decision aid.
Understanding whether clinicians agree on the appropriate treatment options helps us determine the drivers
of variation in the PCI to CABG ratios and clinicians’
willingness to use patient decision aids. The primary aim
of this study was to assess differences between clinicians
on the appropriate treatment options for multivessel coronary artery disease patients, in addition to examining
clinicians’ willingness to use patient decision aids. This
was evaluated through a survey of clinicians in Northern
New England Cardiovascular Disease Study Group. The
survey asked about clinicians’ treatment recommendations and willingness to use a patient decision aid in differing clinical scenarios.

Methods
Participants and setting

This is a cross sectional study of Northern New England
Cardiovascular Study Group (NNECDSG) regular meeting participants. The NNECDSG includes clinical cardiologists and interventional cardiologists, cardiothoracic
surgeons, health services researchers, nurses, technicians,
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and other healthcare providers who work in cardiovascular care and have attended at least one of the Northern
New England Meetings in the past 2 years. The survey
was administered first at an NNECDSG meeting in October 2015, where all meeting attendees completed the survey. NNECDSG regular meeting participants who did
not attend the October meeting received an email version of the survey in July 2016. Emailed survey responses
were accepted through December 2016.
Survey development

The survey, available in the Data Supplement was developed by health services researchers at The Dartmouth
Institute and NNECDSG and informed by a literature
review of factors that influence the choice between
CABG and PCI. The survey included questions about
demographics, attitudes towards patient decision support tools, and questions about treatment recommendations for each of the three clinical vignettes. The attitude
toward patient decision support tools was determined
using a question that asks participants to select words
from a provided list that describe utilizing patient decision support tools. The adjective list includes 10 positive adjectives such as worthwhile and rewarding, and
10 negative adjectives such as difficult and inconvenient
(Additional file 1).
Vignettes are short case histories of theoretical patients
based on real clinic scenarios [3]. Members of the
research team drafted each clinical vignette based on the
characteristics of a pair of matched patients. Matched
patients found in the NNECDSG registry who had similar anatomical characteristics and comorbidities, but had
received different procedures provided the characteristics of patients in each the vignettes. This was done to
ensure each patient in the vignettes could theoretically
be eligible for either CABG or PCI, despite each vignette
having different patient characteristics. We ensured each
vignette had different characteristics that physicians
may weigh differently when choosing treatment strategies. The first vignette is male, 69 years old, and has 80%
left anterior descending artery (LAD), 65% circumflex,
90% right coronary artery (RCA). The second vignette
describes an 81 year-old woman who is diabetic with
80% LAD, 35% diagonal, and 75% circumflex stenosis,
while the third patient is a 63 year-old male with unstable
angina and an 85% LAD, 60% circumflex, and 75% RCA
stenosis. Alternating characteristics of age, diabetes, priority, and anatomical characteristics gave variation to
the patients that might elucidate how physicians choose
different treatment strategies that optimally match
patient characteristics. To ensure all vignettes could be
considered eligible for multiple treatment options, each
vignette patient had normal ventricular function and
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no significant valvular heart disease. Three clinicians,
including a cardiologist and a surgeon, reviewed each
clinical vignette to ensure the vignettes were realistic and
patients could be considered eligible for PCI or CABG as
an appropriate treatment option. After being clinically
reviewed the vignettes were edited and redistributed to
clinician reviewers to ensure any issues were resolved.
The vignettes and a short description of patient characteristics are displayed in Table 1.
For each clinical vignette, the survey asked “Which
treatments are appropriate options for this patient?
Check all that apply.” The possible responses were CABG,
PCI, ad-hoc PCI, and medical therapy only. We also
asked “Would you use the Multi-vessel Coronary Artery
Disease Comparison Table with this patient?” for each
clinical vignette, with possible answers of yes or no. The
Multivessel Coronary Artery Disease Comparison Table
is a one-page clinical encounter patient decision aid
developed with the input of NNECDSG members and
researchers over the previous year. NNECDSG members
vetted evidence, reviewed language, and gave feedback on
the usability of the patient decision support tool. Participants that responded “No” to using the patient decision
aid were asked “If no, what are your main reasons? Check
all that apply.” Response options included: “(1) there is
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only one appropriate treatment option (2) the information in the patient decision aid is not applicable to this
patient because [fill in the blank] (3) I don’t think the
patient would be able to grasp the nuances of the decision (4) I need more information (i.e. FFR, stress test) to
choose the right treatment for the patient. I would need
to know [fill in the blank] (5) other: [fill in the blank].”
Administration

During the plenary session at the NNECDSG envelopes
containing the information sheet, survey, and a blank
envelope were distributed to all attendees (55 members). Members were asked to complete the enclosed
survey, seal it in the blank envelope, and return the survey. Responses were kept anonymous, however we maintained a list of all participating members who attended
the meeting so we could target non-attendees with an
online survey. Survey collection continued throughout
the day with additional announcements to encourage
survey completion during morning, lunch, and afternoon
breaks. Meeting survey data was entered into a standardized electronic data collection form and independently
checked by another research assistant. We used the
NNECDSG email registration list to identify NNECDSG
cardiologists and cardiothoracic surgeons who did not

Table 1 Clinical vignette patients and their characteristics

Smith

Vignette

Characteristics

“Mr. Smith is a 69-year-old with class III stable angina. He first noticed his chest was tight during
his daily swim at the rec center a year ago. After his sister prodded him, he went to the doctor
and tried out different medications. He had a lot of side effects and struggled to find medications that worked for him. He settled into taking aspirin and a beta blocker and most of the
time takes a calcium channel blocker. He still gets chest pain sometimes and avoids one of his
favorite hunting spots because there’s a big hill. After discussing his lingering symptoms and
disappointment with medications with his cardiologist, he is scheduled for a stress test. His
stress test shows evidence of ischemia and his ECHO shows normal ventricular function and
no valve disease. He undergoes a cath. At his cath they find an 80% LAD stenosis, 65% circumflex stenosis, and 90% RCA stenosis.”

Male
69 years old
Rx: aspirin, beta blocker, calcium channel blocker
80% LAD, 65% circumflex, 90% RCA

Adams “Mrs. Adams is 81 years old. She is diabetic and her hemoglobin A1c has been regularly under
7.2% for years. In addition to her diabetes medication, she takes aspirin, a statin, and a beta
blocker. She has class III stable angina and is mainly bothered by her chest pain when she is
working in her garden. Although her symptoms haven’t changed recently, her cousin had a
heart attack last month and at her check-up with her cardiologist she asked if she could do
something more for her heart. She has normal ventricular function and no valve disease. She
and her cardiologist decide it is time to proceed with a cath and she is scheduled for the next
week. During a diagnostic cath, they find an 80% LAD stenosis, a 30% diagonal stenosis, and
75% circumflex stenosis.”

Female
81 years old
Diabetic
Rx: aspirin, statin, beta blocker,
80% LAD, 35% diagonal, 75% circumflex

Jones

Male
63 years old
Rx: aspirin, ACE inhibitor, beta blocker
Unstable angina
85% LAD, 60% circumflex, 75% RCA

“Mr. Jones is a 63-year-old male. He has been managed medically for stable angina for 3 years.
His wife makes sure he takes his aspirin, an ACE inhibitor, and a beta blocker but lately feels
like his medications don’t do as much as they used to. He is not diabetic. Two days ago his
chest pain got worse than normal while on his typical evening walk with his wife. His chest
pain didn’t go away as quickly as usual and lingered through the morning when they decided
to go to the hospital. After he was admitted he had an ECG. It showed no ST or TW changes
and his troponins came back normal. He is scheduled for a cath the following morning. By the
next morning his chest pain is not bothering him anymore, but he and his wife are concerned
enough about his symptoms that they want to proceed with a cardiac cath. The cath shows
an 85% LAD stenosis, a 60% circumflex stenosis, and a 75% RCA stenosis. His LV gram shows
normal ventricular function and no valve disease.”
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attend the 2015 October meeting. These additional
NNECDSG members were emailed a link containing the
survey built within Qualtrics (version 12.2016, Qualtrics,
UT). The email was sent to 49 participants on July 9th
2016 with follow up email reminders every two weeks to
remaining non-responders through December 2016.
Data analysis

The attitude towards patient decision support tools was
determined as positive, neutral, or negative based on the
net positive or negative adjectives selected. We described
the treatment options chosen and willingness to use the
patient decision aid for each vignette. We categorized
participants as surgeons, cardiologists, nurses, or other.
Cardiologists include both clinical and interventional
cardiologists, nurses include nurses and nurse practitioners. The other category includes perfusionists, anesthesiologists, researchers, administrators, and data analysts as
displayed in Table 2. All participants making up the other
category were grouped together because they are not
directly responsible for making treatment decisions with
multivessel coronary artery disease patients.
The treatment choice for each vignette was organized
into the final categories: CABG, PCI, or both. CABG only
reflected participants who chose only CABG, or CABG
and medical therapy. The PCI only category includes
the responses PCI alone, PCI and ad-hoc PCI, PCI and
medical therapy, PCI ad-hoc PCI and medical therapy, or
ad-hoc PCI and medical therapy. Ad-hoc PCI was always
counted as a PCI option. The both category consisted of
any combination of CABG and PCI or ad-hoc PCI such
as CABG or PCI, CABG PCI or medical therapy, CABG
PCI or ad-hoc PCI, CABG PCI ad-hoc PCI or medical
therapy, and CABG or ad-hoc PCI. Medical therapy was
selected alone 5 times (1.9% of all vignette responses) and
was counted as missing when it was the only selected

Table 2 Participant type characteristics

Page 4 of 9

treatment; otherwise the response was categorized with
whichever other treatments were selected.
Treatment selections were compared across participant
type using a generalized Cochran-Mantel–Haenszel test
for association between participant type and treatment
choice stratified by vignette. We then used a multinomial regression model of treatment choice with predictors indicating vignette and participant type and inflating
standard errors for the clusters of observations within
participants. We considered including in the model the
participant’s age, training length, center’s use of patient
decision aids, mode of delivery, and attitude towards
patient decision aids, but none changed the overall point
estimate. We tested for an interaction between participant type and vignette, but did not find a significant interaction. CABG was chosen as the base outcome because it
is considered the most clinically conservative treatment
method. We used a logistic regression of patient decision
aid use by vignette and provider type with random effects
by participant.

Results
Across both distribution modes, 88 (84.6%) NNECDSG
members responded, 55 (100%) of meeting attendees and
33 (67.3%) members receiving emails. Participant characteristics are described in Table 3. Most participants were
cardiologists (33, 37.5%), followed by nurses (19, 21.6%)
others (19, 21.6%) and then cardiothoracic surgeons (17,
19.3%). Twenty-four (27.3%) participants had been out
of training for 20–29 years, and 20 (22.7%) had been out
of training for 30–39 years. Only 40 participants (48.8%)
reported their center used patient decision aids. Most
participants had a positive attitude about patient decision
aids (64, 72.7%).
Treatment choice varied by clinical vignette, for example when comparing vignette 2 to vignette 1, participants
were more likely to choose PCI only over CABG only
(RR 11.13, 95% CI 3.96, 31.28) and both treatments over
CABG only (RR 3.23, 95% CI 1.23, 8.46).

Participant type

Occupation

Cardiologists

Interventional cardiologists

Clinical vignette 1: Mr. Smith

Invasive cardiologists

The Smith clinical vignette describes a 69-year-old
male with 80% LAD stenosis, 65% circumflex stenosis,
and 90% RCA stenosis (Table 1). In the Smith vignette,
39 (34.5%) chose CABG, 12 (14.3%) chose PCI, and 43
(51.2%) chose both (Table 4, Fig. 1). The distribution of
treatment choices across participant types is displayed in
Table 4 and Fig. 2. Surgeons (10, 58.8%) and other participants (8, 53.3%) selected CABG most frequently, while
22 (66.7%) cardiologists and 10 (52.6%) nurses selected a
combination of both treatments most frequently.

General cardiologists
Surgeons

Cardiothoracic surgeons

Nurses

Nurses
Nurse practitioners

Other

Perfusionists
Anesthesiologists
Researchers
Data analysts
Administrators

Nichols et al. BMC Cardiovasc Disord
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Clinical vignette 2: Mrs. Adams

Table 3 Participant characteristics
N

The Adams vignette describes an 81-year-old diabetic
female with 80% LAD stenosis, 35% diagonal stenosis,
and 75% circumflex stenosis (Table 1). In the Adams
vignette, CABG was chosen as an appropriate treatment
option by 8 (10.5%) participants, PCI by 33 (43.4%) participants, and both treatments by 35 (46.1%) participants
(Table 4, Fig. 1). The distribution of treatment choices by
participant types is displayed in Table 4 and Fig. 3. PCI
was selected most frequently by all participant types
except cardiologists, of whom 22 (71.0%) chose both
treatments. PCI was chosen by 8 (50.0%) surgeons, 10
(66.7%) nurses, and 8 (57.1%) other participants.

%

Meeting responder

55

62.5

Online responder

33

37.5

Participant type
Cardiologists

33

37.5

Cardiothoracic surgeons

17

19.3

Nurses

19

21.6

Other

19

21.6

Age, years
18–29

2

2.3

30–39

10

11.4

40–49

20

22.7

50–59

31

35.2

Clinical vignette 3: Mr. Jones

60–69

23

26.1

2

2.3

20–29

24

27.3

30–39

20

22.7

40–49

2

2.3

Still in

2

2.3

12

13.6

40

48.8

The Jones vignette describes a 63-year old male with
unstable angina and a 85% LAD stenosis, 60% circumflex
stenosis, and 75% RCA stenosis. For the Jones vignette,
20 (26.3%) participants chose CABG, 15 (19.7%) chose
PCI, and 41 (54.0%) chose both treatments as appropriate (Table 4). Table 4 and Fig. 4 show the distribution of
treatment choices by participant type. Both treatment
options were most frequently selected with 9 (52.9%)
surgeons, 22 (75.9%) cardiologists, and 6 (40.0%) other
participants. Nurses selected CABG most frequently (6,
40.0%).
Treatment choice

70+
Years since training
0–9

13

14.8

10–19

15

17.1

NA
Center with patient decision aids
Attitude towards patient decision aids
Positive

64

72.7

Neutral

11

12.5

Negative

13

17.8

Across all vignettes, participants chose CABG only 24.2%
of the time, PCI only 25.4% of the time, and both treatment options 50.4% of the time. Therefore 49.6% of the
time, participants chose only one treatment as an appropriate option. Overall, 19 (21.6%) participants chose only
one treatment option for each vignette. A generalized

Table 4 Participant responses to ‘Which treatments are appropriate options for this patient? Check all that apply
Overall

Surgeon

Cardiologists

Nurses

N

N

N

(%)

N

(%)

(%)

CABG

29

(34.5)

10

(58.8)

4

(12.1)

PCI

12

(14.3)

1

(5.9)

7

(21.2)

Both

43

(51.2)

6

(35.3)

22

(66.7)

Other
(%)

N

(%)

7

(36.8)

8

(53.3)

2

(10.5)

2

(13.3)

10

(52.6)

5

(33.3)

Smith

Adams
CABG

8

(10.5)

2

(12.5)

2

(6.5)

1

(6.7)

3

(21.4)

PCI

33

(43.4)

8

(50.0)

7

(22.6)

10

(66.7)

8

(57.1)

Both

35

(46.1)

6

(37.5)

22

(71.0)

4

(26.7)

3

(21.4)

CABG

20

(26.3)

8

(47.1)

1

(3.5)

6

(40.0)

5

(33.3)

PCI

15

(19.7)

0

(0.0)

6

(20.7)

5

(33.3)

4

(26.7)

Both

41

(54.0)

9

(52.9)

22

(75.9)

4

(26.7)

6

(40.0)

Jones

Of coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI), or both by vignette and participant type
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Fig. 1 Percent of participants that selected coronary artery bypass
grafting (CABG), percutaneous coronary intervention (PCI) or both
treatments for each vignette. Treatment selection varied by vignette

Fig. 2 Percent of participants that selected coronary artery bypass
grafting (CABG), percutaneous coronary intervention (PCI) or both
treatments by participant type for the Smith vignette (69 year old
male, 80% LAD, 65% circumflex, and 90% RCA stenosis)

Cochran-Mantel–Haenszel test showed an association
between treatment choice of CABG, PCI, or both and
participant type accounting for vignette (p < 0.0001).
Table 4 shows the results of a multinomial regression
for treatment choice. The clinical vignette significantly
changed treatment choice. For vignette 2 (Adams) compared to vignette 1 (Smith), participants were significantly more likely to choose PCI relative to CABG (RR
11.13, 95% CI 3.96, 31.28) and both treatments relative to
CABG (RR 3.23, 95% CI 1.23, 8.46). In vignette 3 (Jones)
compared to vignette 1 (Smith) there was no difference in
likelihood of choosing PCI over CABG (RR 1.97 95% CI
0.99, 3.90) or choosing both treatments over CABG (1.52,
95% CI 0.93, 2.51).
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Fig. 3 Percent of participants that selected coronary artery bypass
grafting (CABG), percutaneous coronary intervention (PCI) or both
treatments by participant type for the Jones vignette (63 year old
male with unstable angina and 85% LAD, 60% circumflex, and 75%
RCA stenosis)

Fig. 4 Percent of participants that selected coronary artery bypass
grafting (CABG), percutaneous coronary intervention (PCI) or both
treatments by participant type for the Adams vignette (81 year
old female, diabetic with 80% LAD, 35% diagonal, 75% circumflex
stenosis)

Treatment choice was also significantly associated with
participant type. Surgeons were less likely to choose PCI
over CABG (RR 0.14, 95% CI 0.03, 0.59) or both treatments over CABG (RR 0.10, 95% CI 0.03, 0.34) relative
to cardiologists. There was no significant difference in
choosing PCI over CABG between nurses (RR 0.45, 95%
CI 0.10, 1.98) or other participants (RR 0.29, 95% CI 0.07,
1.19) compared to cardiologists. However the likelihood
of choosing both treatments over CABG was significantly
lower in nurses (RR 0.14, 95% CI 0.04, 0.50) and other
participants (RR 0.09, 95% CI 0.03, 0.32) compared to
cardiologists, making cardiologists the most likely participant type to choose both treatments over CABG.
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Patient decision aid use

Forty-seven participants (65.3%) would use the patient
decision aid in every vignette and 8 participants (13.6%)
said they would not use the decision aid in any vignette
(Table 5). Sixty-two participants (73.8%) responded
they would use the patient decision aid with the patient
described in the vignette 1 (Smith). The most common
reason for not using the patient decision aid was ‘Other’
(11, 12.5%) and included the patient decision aid being
too complicated or a disagreement with the data in the
patient decision aid. The second most frequently selected
reason for not using the patient decision aid was ‘there
is only one appropriate treatment option’ selected by 7
(7.95%) participants. In vignette 2 (Adams), 65 participants (80.3%) responded they would use the patient decision aid with the patient. The most common reason for
not using the patient decision aid selected by 6 (9.7%)
participants was needing more information, specifically
fractional flow reserve. In vignette 3 (Jones), 57 participants (73.1%) responded that they would use the patient
decision aid with the patient. The most common reason
for not using the patient decision aid was ‘other’ selected
by 7 (7.95%) participants, often because the risks for the
patient were not represented accurately and participants
felt the risks led to one option being the best for the
patient. The second most common reason for not using
the patient decision aid was ‘there is only one appropriate
treatment option’ selected by 6 (6.8%) participants.
In a logistic model of patient decision aid use, we
included vignette, treatment choice, participant type.
There was no significant difference in decision aid use
in vignette 2 (Adams) (OR: 2.47, 95% CI 0.76, 8.06) or
vignette 3 (Jones) (OR: 1.03, 95% CI 0.34, 2.77) relative

to vignette 1 (Smith). Participants were more likely to
use the patient decision aid when they had selected both
treatments as appropriate (OR: 5.94, 95% CI 1.04, 33.98)
compared to when they selected CABG only. There was
no significant difference in decision aid use when they
selected PCI only compared to CABG only (OR: 1.55,
95% CI 0.19, 12.60). There was no significant difference
in use of patient decision aid in surgeons (OR: 1.36, 95%
CI 0.16, 11.59), nurses (OR: 22.60, 95% CI 0.89, 575.66),
or other participants (OR: 4.59, 95% CI 0.34, 61.12) compared to cardiologists.

Discussion
Participant’s opinions of appropriate treatment options
varied based on vignette and participant specialty. Both
PCI and CABG options were chosen together as appropriate treatments only 50.4% of the time, and the remaining 49.6% of the time only one treatment option was
chosen as appropriate. Participants were more likely to
select PCI or both treatments as appropriate over CABG
for the Adams vignette relative to the Smith vignette.
Cardiologists were the most likely participant type to
choose both treatments over CABG alone. Surgeons
were the only participant specialty significantly less likely
to choose PCI over CABG compared to cardiologists.
Overall, 65% of participants thought they would use the
patient decision aid with every vignette, even though
53.2% of these participants chose only one treatment
option in at least one of the clinical vignettes. Patient
decision support tool use was more likely when both
CABG and PCI were chosen as appropriate treatment
options, but was not influenced by vignette or participant
type.

Table 5 Multinomial regression of treatment choice of percutaneous coronary intervention (PCI), or both PCI and coronary artery
bypass grafting (CABG) compared to CABG as the reference group
Univariate Model
CABG (ref)

PCI
RR

Full Model
Both

(95% CI)

RR

PCI
(95% CI)

RR

Both
(95% CI)

RR

(95% CI)

Vignette
Smith

1

ref

1

ref

1

ref

1

ref

Adams

9.97

(3.75, 26.49)

2.95

(1.29, 6.73)

11.13

(3.96, 31.28)

3.23

(1.23, 8.46)

Jones

1.81

(0.93, 3.52)

1.38

(0.90, 2.13)

1.97

(0.99, 3.90)

1.52

(0.93, 2.51)

Participant
type
Cardiologist 1

ref

1

ref

1

ref

1

ref

Surgeon

(0.04, 0.58)

0.11

(0.04, 0.35)

0.14

(0.03, 0.59)

0.10

(0.03, 0.34)

0.16

Nurse

0.43

(0.11, 1.59)

0.14

(0.04, 0.47)

0.45

(0.10, 1.98)

0.14

(0.04, 0.50)

Other

0.31

(0.09, 1.05)

0.09

(0.03, 0.32)

0.29

(0.07, 1.19)

0.09

(0.03, 0.32)

Relative risk (RR) reflects the relative likelihood of choosing PCI or both treatments over CABG, compared to that of the referent group in each variable
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Past studies have shown differences among healthcare provider type in care recommendations [13].
McIlvennan described variation in cardiologists’ and
hospice/palliative medicine clinicians’ views of left ventricular assist device deactivation [14]. This included
their approach and comfort with deactivation of left
ventricular assist devices [14]. In a survey of French
cardiologists looking at care management choices for
stable coronary artery disease patient vignettes, Bauters
and colleagues found practice patterns in even routine
clinical situations such as β-blocker prescription, or
management for recurrent chest pain after revascularization vary when there are no high-level practice guidelines [8].
In observational studies, variation in revascularization rates have been attributed to patient factors,
similar to our finding that treatment selections change
based on clinical vignettes [15]. An analysis of Ontario
patients with stable ischemic heart disease showed
67.4% of the variation in revascularization strategies
was due to patient factors [15]. However, when examining use of PCI and CABG across Ontario and New York
State, rates of PCI were higher in New York, most likely
related to the different reimbursement approaches in
Ontario and New York [2]. Other studies have documented hospital ‘cultural’ effects, and physician type
impacting revascularization strategy, in addition to
patient factors [1].
This study has a number of limitations, which must be
considered while interpreting results. The surveys were
completed by a small sample of clinicians in northern
New England, and their opinions may be influenced by
the local culture of practice. The vignettes could not feasibly include all potentially relevant clinical details that
may affect treatment choice. Additionally the vignettes
did not include explicit patient preferences, which could
also impact the treatment choice selected by the participant. To more closely examine which clinical factors
influence treatment selection, vignettes with systematically varied clinical factors could be used in a combination with prediction models from registries [6, 16]. Other
system factors such as reimbursement structure, hospital
culture, volume and availability or procedures also could
not be accounted for in this study.
One next step to validate these findings and further
explore the variation in provider preferences for treatment of multivessel disease, is to administer this survey
at a national level with the NCDR and STS jointly. The
inclusion of cardiac catheterization images or video and
inclusion of patient preferences, occupation, medical
insurance, and living situation could also help to improve
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the evaluation of variation in provider specialty preferences for multivessel coronary artery disease.

Conclusions
There is a lack of consensus on the appropriate treatment
options across cardiologists and surgeons for patients with
multivessel coronary artery disease. Treatment choice
is influenced by both patient characteristics and clinician type. Although most participants were willing to use
a patient decision support tool, many participants did not
consider the vignette patients eligible for more than one
treatment which could affect their likelihood of consulting
with other clinical team members during decision making
or using a patient decision aid.
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